Valuation: PeptiDream Inc.

Market Cap 143B 911M 802M 760M 686M 1.29B 87.35B 1.31B 9.09B 3.5B 44.65B 3.42B 3.35B P/E 2026 *
21.3x
P/E 2027 * 15.3x
Enterprise Value 130B 827M 728M 690M 623M 1.17B 79.31B 1.19B 8.26B 3.18B 40.55B 3.11B 3.04B EV / Sales 2026 *
3.61x
EV / Sales 2027 * 3.01x
Free-Float
72.25%
Yield 2026 *
-
Yield 2027 * 0.36%
1 day+5.70%
1 week+4.07%
Current month+2.16%
1 month-0.09%
3 months+4.41%
6 months-6.94%
Current year-32.78%
1 week 1,039.5
Extreme 1039.5
1,121
1 month 1,028
Extreme 1028
1,121
Current year 906.4
Extreme 906.4
1,788
1 year 906.4
Extreme 906.4
1,793
3 years 906.4
Extreme 906.4
3,060
5 years 906.4
Extreme 906.4
3,615
10 years 906.4
Extreme 906.4
6,540
Manager TitleAgeSince
Chief Executive Officer 51 31/12/2021
Chief Operating Officer - 01/07/2026
Chief Tech/Sci/R&D Officer - 31/03/2024
Director TitleAgeSince
Director/Board Member 51 31/07/2008
Director/Board Member 51 31/08/2017
Director/Board Member 55 28/02/2021
Change 5-day change 1-year change 3-year change Capi.($)
+5.70%+4.07%-29.44%-30.88% 859M
+4.16%-0.30%+58.96%+94.17% 71.53B
-0.19%+1.32%+37.20%+81.33% 60.12B
-1.51%+2.39%+9.10%+36.79% 48.85B
+0.73%+1.08%+42.55%+39.65% 44.28B
+1.31%+8.55%+343.34%+691.13% 43.83B
+1.30%+1.61%+8.86%+107.78% 41.53B
-0.67%-0.45%+4.47%+46.37% 30.13B
+4.77%+6.46%+41.54%+22.78% 27.98B
+0.24%-1.94%-19.42%+357.39% 25.25B
Average +1.62%+0.28%+49.72%+144.65% 39.44B
Weighted average by Cap. +1.27%+0.62%+63.34%+154.63%

Financials

2026 *2027 *
Net sales 36.04B 229M 202M 191M 173M 326M 21.99B 330M 2.29B 881M 11.24B 861M 842M 41.41B 264M 232M 220M 198M 374M 25.27B 379M 2.63B 1.01B 12.92B 990M 968M
Net income 6.77B 43.05M 37.91M 35.92M 32.43M 61.12M 4.13B 61.91M 430M 165M 2.11B 162M 158M 9.39B 59.73M 52.6M 49.83M 44.99M 84.79M 5.73B 85.89M 596M 229M 2.93B 224M 219M
Net Debt -13.16B -83.77M -73.77M -69.89M -63.1M -119M -8.03B -120M -836M -322M -4.11B -315M -308M -18.42B -117M -103M -97.79M -88.29M -166M -11.24B -169M -1.17B -450M -5.75B -440M -431M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
763
Date Price Change Volume
30/09/26 JP¥1,113.50 +5.70% 1,396,900
29/09/26 JP¥1,053.50 -1.17% 517,300
28/09/26 JP¥1,066.00 -0.28% 694,100
25/09/26 JP¥1,069.00 +1.18% 494,300
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,113.50JPY
Average target price
2,608.33JPY
Spread / Average Target
+134.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock